Compare WGS & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WGS | PNTG |
|---|---|---|
| Founded | 2017 | 2019 |
| Country | United States | United States |
| Employees | 1300 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | N/A | 2019 |
| Metric | WGS | PNTG |
|---|---|---|
| Price | $56.46 | $34.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $120.71 | $37.00 |
| AVG Volume (30 Days) | ★ 1.2M | 206.3K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $947,705,000.00 |
| Revenue This Year | $29.98 | $24.72 |
| Revenue Next Year | $25.92 | $7.61 |
| P/E Ratio | $1,251.58 | ★ $141.17 |
| Revenue Growth | N/A | ★ 36.31 |
| 52 Week Low | $32.21 | $21.74 |
| 52 Week High | $170.87 | $37.54 |
| Indicator | WGS | PNTG |
|---|---|---|
| Relative Strength Index (RSI) | 51.16 | 57.18 |
| Support Level | $32.21 | $28.05 |
| Resistance Level | $73.46 | $35.13 |
| Average True Range (ATR) | 4.21 | 1.58 |
| MACD | 1.05 | 0.15 |
| Stochastic Oscillator | 42.45 | 82.21 |
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.